News

Every milestone reflects our commitment to innovating with purpose. Read the latest press releases and announcements from StimLabs.

News

Every milestone reflects our commitment to innovating with purpose. Read the latest press releases and announcements from StimLabs.

StimLabs Announces Commercial Launch of DermaForm, a Uniquely Engineered Collagen Scaffold Particulate Device

PR Newswire
November 3, 2026
Read More

StimLabs Announces the Launch of Architect, a Novel Advanced Collagen Matrix Device for Wound Care

PR Newswire
March 3, 2026
Read More

StimLabs Announces FDA 510(k) Clearance for DermaForm, a Collagen Scaffold Particulate Wound Care Device

PR Newswire
February 12, 2026
Read More

StimLabs and Geistlich Expand Their Partnership with a New Product Anticipated Q2 2026

PR Newswire
January 12, 2026
Read More

Stimlabs LLC Announces Launch of Allacor P – The First FDA 510(k) Cleared Human Umbilical Cord Particulate Device for Wound Management

PR Newswire
January 5, 2026
Read More

StimLabs Announces FDA Clearance of Theracor: The First Human Umbilical Cord-Derived Medical Device Sheet

PR Newswire
December 29, 2025
Read More

StimLabs Announces New Real-World Study Demonstrating Positive Outcomes Using Relese in the Treatment of Chronic Wounds

PR Newswire
October 31, 2025
Read More

StimLabs Achieves ISO 13485:2016 Certification, Solidifying Leadership Position Among Industry

PR Newswire
September 24, 2025
Read More

StimLabs Awarded Regenerative Biologics Contract with Vizient

PR Newswire
August 4, 2025
Read More

StimLabs Announces Exclusive Distribution Rights for Geistlich’s Wound Care Portfolio

PR Newswire
November 26, 2024
Read More

StimLabs Announces National Availability of Corplex P

PR Newswire
October 2, 2024
Read More

StimLabs Announces Enrollment of First Patient in CAMPSTIM Trial for Hard-to-Heal Diabetic Foot Ulcers

PR Newswire
July 18, 2024
Read More

StimLabs Announces IRB Approval for CAMPSTIM: The Largest Prospective Placental Tissue Allograft Trial for Diabetic Foot Ulcers

PR Newswire
June 4, 2024
Read More

StimLabs awarded Reconstructive Skin Grafting products agreement with Premier, Inc.

PR News Wire
March 5, 2024
Read More

FDA Clears Groundbreaking Corplex P: The First Human Umbilical Cord-Derived Medical Device Corplex P

PR Newswire
February 6, 2024
Read More

Stimlabs LLC Granted Issuance of Two New Patents Further Establishing the Company’s Intellectual Property Position for Advancements in Regenerative Medicine

Access Newswire
November 1, 2023
Read More

Stimlabs LLC Announces Launch of Relese – A Uniquely Fenestrated Allograft for Chronic and Acute Wounds

PR Newswire
August 24, 2023
Read More

Revita Revolutionizes Patient Care

MedEsthetics
August 3, 2021
Read More

Placental allograft, cytology processor, cell-free RNA testing, and male infertility

MDedge
July 7, 2021
Read More

StimLabs Announces Department of Veterans Affairs (VA) And Department of Defense (DoD) Agreements

PR Newswire
December 10, 2018
Read More

StimLabs Announces Enrollment of First Patient in Evaluating Efficacy of Full Thickness Placental Allograft, Revita, in Lumbar Microdiscectomy Outcomes

PR Newswire
June 19, 2018
Read More

StimLabs Announces Partnership with American Military Medical Organization, LLC

PR Newswire
August 1, 2017
Read More

StimLabs Enters Regenerative Medicine Market with Two Groundbreaking Amniotic Tissue Products

PR Newswire
July 25, 2017
Read More

Beyond the Headlines

From where we started to our growing product portfolio, see what defines StimLabs.

Read Our Story
View Our Product Portfolio